<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85464</article-id><article-id pub-id-type="doi">10.7554/eLife.85464</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-300693"><name><surname>Zhang</surname><given-names>Zengdi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-300694"><name><surname>Huang</surname><given-names>Zan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300695"><name><surname>Awad</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300696"><name><surname>Elsalanty</surname><given-names>Mohammed</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300697"><name><surname>Cray</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41573"><name><surname>Ball</surname><given-names>Lauren E</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52505"><name><surname>Maynard</surname><given-names>Jason C</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4366"><name><surname>Burlingame</surname><given-names>Alma L</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232310"><name><surname>Zeng</surname><given-names>Hu</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-221664"><name><surname>Mansky</surname><given-names>Kim C</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-192844"><name><surname>Ruan</surname><given-names>Hai-Bin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3858-1272</contrib-id><email>hruan@umn.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017zqws13</institution-id><institution>Department of Integrative Biology and Physiology, University of Minnesota Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05td3s095</institution-id><institution>Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University</institution></institution-wrap><addr-line><named-content content-type="city">Nanjing</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05td3s095</institution-id><institution>National Center for International Research on Animal Gut Nutrition, Nanjing Agricultural University</institution></institution-wrap><addr-line><named-content content-type="city">Nanjing</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05167c961</institution-id><institution>Department of Medical Anatomical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Pomona</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Department of Biomedical Education and Anatomy, The Ohio State University College of Medicine, and Division of Biosciences, The Ohio State University College of Dentistry</institution><addr-line><named-content content-type="city">Columbus</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012jban78</institution-id><institution>Department of Cell and Molecular Pharmacology &amp; Experimental Therapeutics, Medical University of South Carolina</institution></institution-wrap><addr-line><named-content content-type="city">Charleston</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Pharmaceutical Chemistry, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Division of Rheumatology, Department of Internal Medicine, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Department of Immunology, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017zqws13</institution-id><institution>Department of Developmental and Surgical Sciences, School of Dentistry, University of Minnesota</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017zqws13</institution-id><institution>Center for Immunology, University of Minnesota Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Minneapolis</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yang</surname><given-names>Yunlei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Albert Einstein College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>02</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85464</elocation-id><history><date date-type="received" iso-8601-date="2022-12-08"><day>08</day><month>12</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-01"><day>01</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-12-21"><day>21</day><month>12</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.12.21.521379"/></event></pub-history><permissions><copyright-statement>© 2023, Zhang, Huang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zhang, Huang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85464-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-85464-figures-v2.pdf"/><abstract><p>In mammals, interactions between the bone marrow (BM) stroma and hematopoietic progenitors contribute to bone-BM homeostasis. Perinatal bone growth and ossification provide a microenvironment for the transition to definitive hematopoiesis; however, mechanisms and interactions orchestrating the development of skeletal and hematopoietic systems remain largely unknown. Here, we establish intracellular O-linked β-N-acetylglucosamine (O-GlcNAc) modification as a posttranslational switch that dictates the differentiation fate and niche function of early BM stromal cells (BMSCs). By modifying and activating RUNX2, O-GlcNAcylation promotes osteogenic differentiation of BMSCs and stromal IL-7 expression to support lymphopoiesis. In contrast, C/EBPβ-dependent marrow adipogenesis and expression of myelopoietic stem cell factor (SCF) is inhibited by O-GlcNAcylation. Ablating O-GlcNAc transferase (OGT) in BMSCs leads to impaired bone formation, increased marrow adiposity, as well as defective B-cell lymphopoiesis and myeloid overproduction in mice. Thus, the balance of osteogenic and adipogenic differentiation of BMSCs is determined by reciprocal O-GlcNAc regulation of transcription factors, which simultaneously shapes the hematopoietic niche.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>bone</kwd><kwd>bone marrow</kwd><kwd>hematopoiesis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32170847</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Zan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI162678</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Hu</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI139420</award-id><principal-award-recipient><name><surname>Ruan</surname><given-names>Hai-Bin</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI162791</award-id><principal-award-recipient><name><surname>Ruan</surname><given-names>Hai-Bin</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Maynard</surname><given-names>Jason C</given-names></name><name><surname>Burlingame</surname><given-names>Alma L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>OGT-mediated protein O-GlcNAcylation balances osteogenic versus adipogenic differentiation and controls hematopoietic niche function of bone marrow stromal cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mammalian bones support body structure, protect vital organs, and allow body movement. In addition, they provide an environment for hematopoiesis in the bone marrow (BM). Most bones in mammals are formed through endochondral ossification, which is initiated by mesenchymal condensation, followed by the differentiation of chondrocytes and perichondrial progenitors (<xref ref-type="bibr" rid="bib35">Kobayashi and Kronenberg, 2021</xref>). Perichondrial progenitors expressing Osterix (encoded by the <italic>Sp7</italic> gene) co-migrate with blood vessels into the primary ossification center, giving rise to osteoblasts and transient stromal cells in the nascent BM cavity (<xref ref-type="bibr" rid="bib14">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib42">Maes et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Mizoguchi et al., 2014</xref>). At the perinatal stage, Osterix<sup>+</sup> progenitors contribute to osteo-lineages and long-lived BM stromal cells (BMSCs) that exhibit trilineage differentiation potential into osteocytes, chondrocytes, and adipocytes.</p><p>The decision of BMSC fate is controlled by a transcriptional network of pro-osteogenic and anti-adipogenic transcription factors that pre-establishes osteogenic enhancers in BMSCs for rapid bone formation (<xref ref-type="bibr" rid="bib52">Rauch et al., 2019</xref>). RUNX family transcription factor 2 (RUNX2), by regulating osteogenic genes including <italic>Sp7</italic>, determines the osteoblast lineage from the multipotent BMSCs. Mice with <italic>Runx2</italic> mutations completely lack skeletal ossification and die of respiratory failure (<xref ref-type="bibr" rid="bib36">Komori et al., 1997</xref>). <italic>Runx2</italic>-haploinsufficient mice show specific skeletal abnormalities characteristic of human cleidocranial dysplasia (CCD), including persistent fontanels, delayed closure of cranial sutures, rudimentary clavicles, and dental abnormalities (<xref ref-type="bibr" rid="bib49">Otto et al., 1997</xref>; <xref ref-type="bibr" rid="bib63">Takarada et al., 2016</xref>). On the other hand, adipogenesis is driven by downregulation of pro-osteogenic factors, remodeling of the chromatin, and activation of adipogenic transcription factors, such as C/EBPs and PPARγ (<xref ref-type="bibr" rid="bib1">Aaron et al., 2021</xref>; <xref ref-type="bibr" rid="bib52">Rauch et al., 2019</xref>). BM adiposity is associated with bone loss in osteoporosis caused by aging, menopause, and anorexia nervosa (<xref ref-type="bibr" rid="bib8">Bethel et al., 2013</xref>; <xref ref-type="bibr" rid="bib21">Fazeli et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Scheller et al., 2016</xref>). However, it is incompletely understood how these distinct types of transcription factors act cooperatively to determine lineage differentiation during neonatal skeletal development.</p><p>BMSCs and their lineage-differentiated progeny (e.g. osteoblasts and adipocytes) provide a niche microenvironment for hematopoiesis (<xref ref-type="bibr" rid="bib9">Bianco and Robey, 2015</xref>; <xref ref-type="bibr" rid="bib11">Calvi and Link, 2015</xref>; <xref ref-type="bibr" rid="bib45">Morrison and Scadden, 2014</xref>; <xref ref-type="bibr" rid="bib66">Wei and Frenette, 2018</xref>). Recent studies using single-cell technologies and lineage tracing experiments have started to unveil the complexity and heterogeneity of niche cell types, niche factors, and their actions. For example, BMSC-derived stem cell factor (SCF, encoded by the <italic>Kitl</italic> gene) and CXC chemokine ligand 12 (CXCL12) are required for the maintenance and differentiation of hematopoietic stem/progenitor cells (HSPCs) (<xref ref-type="bibr" rid="bib6">Asada et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Ding et al., 2012</xref>). A prominent subpopulation of perivascular BMSCs express adipocyte markers (<xref ref-type="bibr" rid="bib20">Dolgalev and Tikhonova, 2021</xref>; <xref ref-type="bibr" rid="bib74">Zhong et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Zhou et al., 2017</xref>), and support steady-state and metabolic-stressed myelopoiesis by secreting SCF (<xref ref-type="bibr" rid="bib70">Zhang et al., 2019</xref>). Meanwhile, osteolineage cells are crucial for lymphopoiesis (<xref ref-type="bibr" rid="bib66">Wei and Frenette, 2018</xref>). Depleting Osterix<sup>+</sup> cells halts B cell maturation and causes immune failure (<xref ref-type="bibr" rid="bib69">Yu et al., 2016</xref>). IL-7, the most crucial factor for lymphoid progenitors, is expressed by a subset of BMSCs (<xref ref-type="bibr" rid="bib22">Fistonich et al., 2018</xref>). While it is well accepted that myeloid and lymphoid progenitors may reside in distinct BM niches, it is unclear how BMSC heterogeneity is established during early development and whether cytokine expression is coordinated and controlled by the fate-defining transcriptional network in BMSCs.</p><p>Post-translational modifications (PTMs), including phosphorylation, acetylation, and ubiquitination, allow the precise regulation of stability, localization, and activity of BM transcriptional factors, such as RUNX2 (<xref ref-type="bibr" rid="bib15">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib34">Kim et al., 2020</xref>), C/EBPs (<xref ref-type="bibr" rid="bib65">Wang et al., 2022</xref>), and PPARγ (<xref ref-type="bibr" rid="bib10">Brunmeir and Xu, 2018</xref>). It remains poorly defined how these modifications are coordinated in a spatio-temporal manner to calibrate skeletal development. Thousands of intracellular proteins are dynamically modified by a single O-linked N-Acetylglucosamine (O-GlcNAc) moiety at serine or threonine residues, termed O-GlcNAcylation (<xref ref-type="bibr" rid="bib27">Hart et al., 2007</xref>; <xref ref-type="bibr" rid="bib55">Ruan et al., 2013b</xref>; <xref ref-type="bibr" rid="bib68">Yang and Qian, 2017</xref>). O-GlcNAc transferase (OGT), using UDP-GlcNAc derived from the hexosamine biosynthetic pathway as the substrate, controls diverse biological processes such as gene transcription, protein stability, and cell signaling (<xref ref-type="bibr" rid="bib24">Hanover et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Ruan et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Ruan et al., 2012</xref>; <xref ref-type="bibr" rid="bib54">Ruan et al., 2013a</xref>). In cell culture, O-GlcNAcylation promotes osteogenesis (<xref ref-type="bibr" rid="bib33">Kim et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Nagel and Ball, 2014</xref>) and suppresses adipogenesis (<xref ref-type="bibr" rid="bib31">Ji et al., 2012</xref>). However, the physiological relevance of O-GlcNAcylation in skeletal development and remodeling has not been established. Here, we studied OGT in balancing osteogenic versus adipogenic programs and in controlling niche function of BMSC in mice. The multifaceted role of protein O-GlcNAcylation is achieved through reciprocal regulation of pro-osteogenic, pro-lymphopoietic RUNX2 and pro-adipogenic, pro-myelopoietic C/EBPβ.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Loss of OGT in perinatal BMSCs leads to bone loss</title><p>To determine the in vivo role of protein O-GlcNAcylation in bone development, we deleted the X Chromosome-located <italic>Ogt</italic> gene using the <italic>Sp7<sup>GFP:Cre</sup></italic> mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Floxed <italic>Ogt<sup>fl/fl</sup></italic> were bred with <italic>Sp7<sup>GFP:Cre</sup></italic> to generate <italic>Ogt</italic> conditional knockout (cKO) mice. Compared to <italic>Sp7<sup>GFP:Cre</sup></italic> littermate controls, newborn <italic>Ogt</italic> cKO mice showed no obvious change in long bone formation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) but had a profound defect in the mineralization of flat bones of the calvaria (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), suggesting impaired intramembranous ossification during the prenatal stage.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Impaired osteogenesis in <italic>Ogt</italic> cKO mice.</title><p>(<bold>A</bold>) Mating strategy to generate <italic>Ogt</italic> cKO mice. Note that the <italic>Ogt</italic> gene is located on Chr. X, thus males are hemizygous <italic>Ogt<sup>fl/Y</sup></italic>. (<bold>B, C</bold>) Whole mount Alizarin red and Alcian blue staining of newborn mice. (<bold>D, E</bold>) Long bone length (<bold>D</bold>) and gross morphology of 4–6 weeks old mice. (<bold>F, G</bold>) Goldner’s trichrome (<bold>F</bold>) and Safranin O (<bold>G</bold>) staining of femurs from 4-week-old mice. (<bold>H–L</bold>) Micro-CT of 6-week-old mice (<bold>H</bold>, n=3–4). Bone volume (BV, <bold>I</bold>), BV/tissue volume ratio (BV/TV, <bold>J</bold>), trabecular thickness (Tb.Th, <bold>K</bold>), and trabecular number (Tb.N, <bold>L</bold>) were calculated. Data are presented as mean ± SEM. *, p&lt;0.05 by unpaired student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Dental defects of <italic>Ogt</italic> cKO mice.</title><p>Top: photographic analysis of incisor tooth development. Bottom: photographic analysis of molar tooth development.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig1-figsupp1-v2.tif"/></fig></fig-group><p>At 4–6 weeks of age, <italic>Ogt</italic> cKO mice were modestly shorter than the controls (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). Histological analyses showed decreased bone volume and osteoblast number (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) and shortened growth plate (<xref ref-type="fig" rid="fig1">Figure 1G</xref>) in <italic>Ogt</italic> cKO mice. Micro-CT scanning further showed that <italic>Ogt</italic> cKO mice had reduced trabecular bone volume, bone volume to tissue volume ratio, trabecular thickness, and trabecular numbers in the distal femur (<xref ref-type="fig" rid="fig1">Figure 1H–L</xref>). <italic>Ogt</italic> cKO mice represent typical bone and dental defects (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) as observed in <italic>Runx2</italic>-haploinsufficient mice (<xref ref-type="bibr" rid="bib49">Otto et al., 1997</xref>; <xref ref-type="bibr" rid="bib63">Takarada et al., 2016</xref>), suggesting that O-GlcNAcylation might control RUNX2 function. Moist food was provided to these animals after weaning to prevent malnutrition.</p></sec><sec id="s2-2"><title>RUNX2 O-GlcNAcylation promotes osteogenesis</title><p>To investigate how OGT controls osteogenic differentiation of BMSCs, we first isolated primary BMSCs from control and <italic>Ogt</italic> cKO mice and induced them into osteoblast cells. Alkaline phosphatase staining revealed a reduction in mineralization of <italic>Ogt</italic> cKO BMSCs (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Similarly, treating mesenchymal C3H10T1/2 cells with an OGT inhibitor, OSMI-1, reduced mineralization (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and ablated calcium deposition (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) after osteogenic differentiation. Parathyroid hormone (PTH) is a bone anabolic agent that requires RUNX2-dependent signaling (<xref ref-type="bibr" rid="bib37">Krishnan et al., 2003</xref>). We found that PTH treatment of C3H10T1/2 cells increased global protein O-GlcNAcylation (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The ability of PTH to activate osteogenesis is completely abolished when OGT was inhibited by OSMI-1 (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Pharmacological activation of O-GlcNAcylation enhances RUNX2 activity and promotes osteogenic differentiation (<xref ref-type="bibr" rid="bib33">Kim et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Nagel and Ball, 2014</xref>). We mutated three known O-GlcNAc sites on RUNX2, Ser 32 and Ser 33 in the N-terminal transactivation domain and Ser 371 in the proline/serine/threonine-rich domain (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), to alanine (3A), and found that mutant RUNX2 possessed less O-GlcNAcylation (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). O-GlcNAcase (OGA) inhibition by Thiamet-G (TMG) increased O-GlcNAcylation of wildtype (WT) RUNX2, but to a much less extent in the 3A mutant (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). OGT inhibition by OSMI-1 or O-GlcNAc mutation both impaired the transcriptional activity of RUNX2 on a luciferase reporter (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). OSMI-1 could still suppress of luciferase activity of RUNX2-3A (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), suggesting additional, unidentified O-GlcNAc sites (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), which requires future investigation. Nevertheless, when overexpressed in C3H10T1/2 cells, RUNX2-3A substantially lost the ability to induce osteogenic differentiation (<xref ref-type="fig" rid="fig2">Figure 2I</xref>) or RUNX2-target gene expression (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). These data demonstrate that O-GlcNAcylation is essential for RUNX2 activity and osteogenesis.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>RUNX2 O-GlcNAcylation is required for osteogenesis.</title><p>(<bold>A</bold>) Alkaline phosphatase (ALP) staining of control and <italic>Ogt</italic> cKO BMSCs differentiated to the osteogenic lineage. (<bold>B, C</bold>) Primary BMSCs, in the presence or absence of the OGT inhibitor OSMI-1, were induced for osteogenesis and stained for ALP (<bold>B</bold>) and Alizarin Red S (<bold>C</bold>). (<bold>D</bold>) Primary BMSCs were treated with PTH for the indicated time and subjected to Western blotting of total protein O-GlcNAcylation. (<bold>E</bold>) BMSCs were treated with PTH alone or together with OSMI-1, osteogenic differentiated, and stained for ALP (n=3). (<bold>G</bold>) Flag-tagged wildtype (WT) and O-GlcNAc mutant (3A) RUNX2 plasmids were overexpressed in HEK293 cells, and their O-GlcNAcylation was determined by Flag immunoprecipitation followed with O-GlcNAc western blot. (<bold>H</bold>) 6xOSE-luciferase activity in COS-7 cells transfected with WT or 3A-mutant RUNX2, in the presence or absence of the OGT inhibitor, OSMI-1. (<bold>I, J</bold>) C3H10T1/2 cells with lentiviral overexpression of RUNX2 were osteogenically differentiated and stained with ALP or Alizarin Red S (<bold>I</bold>). Expression of <italic>Bglap</italic> and <italic>Rankl</italic> was determined by RT-qPCR (<bold>J</bold>). Data are presented as mean ± SEM. *, p&lt;0.05; **, p&lt;0.01; and ***, p&lt;0.001 by two-way ANOVA (<bold>H</bold>) or one-way ANOVA (<bold>J</bold>). Representative images from at least three biological replicates were shown in A, B, C, E, and I.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw uncropped images for panel D.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig2-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Raw uncropped images for panel G.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig2-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig2-v2.tif"/></fig><p>In adult mice, <italic>Sp7</italic> expression is restricted to osteoblast precursors. We treated <italic>Ogt</italic> cKO mice from pregnancy with doxycycline (Dox) and withdrew Dox at 10 weeks of age to induce Cre expression and OGT depletion only during adulthood (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Micro-CT showed that <italic>Ogt</italic> cKO mice had reduced bone volume, trabecular thickness, and bone mineral density (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>). Together, these results support the functional indispensability of OGT in the committed osteolineage for adult trabecular bone remodeling.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Adult-onset deletion of OGT impairs trabecular bone formation.</title><p>(<bold>A</bold>) Dox treatment timeline in <italic>Ogt</italic> cKO to achieve osteoblast-specific deletion of OGT. (<bold>B–D</bold>) Micro-CT (<bold>B</bold>) showing reduced bone volume/tissue volume (<bold>C</bold>), trabecular thickness (<bold>D</bold>), and trabecular bone mineral density (<bold>E</bold>). Data are presented as mean ± SEM.*, p&lt;0.05 by unpaired student’s t-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig3-v2.tif"/></fig></sec><sec id="s2-3"><title>C/EBPβ O-GlcNAcylation inhibits the adipogenic specification of BMSCs</title><p>The osteogenic and adipogenic differentiation of BMSCs is generally considered mutually exclusive (<xref ref-type="bibr" rid="bib3">Ambrosi et al., 2017</xref>). Concomitant with bone loss, we observed a massive accumulation of adipocytes in the bone marrow of <italic>Ogt</italic> cKO mice, shown by hematoxylin &amp; eosin staining (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and immune-staining of the lipid droplet protein – perilipin (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). <italic>Pdgfrα</italic> and <italic>Vcam1</italic> (encoding CD106) have been recently identified as surface markers of adipogenic lineage cells in the BM that also express the <italic>Lepr</italic> and <italic>Adipoq</italic> genes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib7">Baryawno et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Zhong et al., 2020</xref>). Flow cytometric analysis of BMSCs revealed that <italic>Ogt</italic> cKO mice possessed more PDGFRα<sup>+</sup>VCAM1<sup>+</sup> adipogenic progenitors than littermate controls (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). To directly test if OGT deficiency biases BMSC differentiation toward the adipogenic lineage, we first induced the adipogenic differentiation of primary BMSCs and found increased lipid deposition in <italic>Ogt</italic> cKO mice (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Even under an osteogenic induction condition, adipo-lineage markers such as <italic>Adipoq</italic> and <italic>Vcam1</italic> were significantly upregulated by OGT deficiency (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). Furthermore, treating C3H10T1/2 mesenchymal cells with an OGA inhibitor TMG to increase protein O-GlcNAcylation, was able to substantially reduce perilipin protein expression (<xref ref-type="fig" rid="fig4">Figure 4G</xref>) and <italic>Pparg</italic> and <italic>Adipoq</italic> gene expression (<xref ref-type="fig" rid="fig4">Figure 4H, I</xref>). These data indicate that OGT inhibits the adipogenic program of BMSCs.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>O-GlcNAcylation inhibits BM adipogenesis.</title><p>(<bold>A, B</bold>) H&amp;E (<bold>A</bold>) and Perilipin immunofluorescent staining (<bold>B</bold>) on femur sections from 4-week-old mice. (<bold>C</bold>) Flow cytometric quantification of PDGFRa<sup>+</sup>VCAM1<sup>+</sup> preadipocytes frequencies within the live BM cells (n=3). (<bold>D</bold>) Adipogenic differentiation of primary BMSCs from control and <italic>Ogt</italic> cKO mice. Lipid was stained with Oil Red O and quantified to the right (n=4). (<bold>E, F</bold>) Primary BMSCs were osteogenic differentiated for 0 or 15 days. Expression of <italic>Adipoq</italic> (<bold>E</bold>) and <italic>Vcam1</italic> (<bold>F</bold>) genes was determined by RT-qPCR (n=3). (<bold>G–I</bold>) C3H10T1/2 cells, treated with or without TMG, were adipogenic differentiated. Western blotting for perilipin and O-GlcNAc of differentiated cells (<bold>G</bold>) and RT-qPCR for adipogenic marker <italic>Pparg</italic> (<bold>H</bold>) and <italic>Adipoq</italic> (<bold>I</bold>) expression. (<bold>J–M</bold>) Adipogenic differentiation of C3H10T1/2 cells infected with lentiviral C/EBPβ. Oil Red O was stained (<bold>J</bold>) and quantified (<bold>K</bold>). <italic>Pparg</italic> (<bold>L</bold>) and <italic>Adipoq</italic> (<bold>M</bold>) gene expression was determined by RT-qPCR. Data are presented as mean ± SEM.*, p&lt;0.05; **, p&lt;0.01; and ***, p&lt;0.001 by unpaired student’s t-test (<bold>C, D, K</bold>), one-way ANOVA (<bold>L, M</bold>), and two-way ANOVA (<bold>E, F, H, I</bold>).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Mass spectrometry search results of all protein modifications (Table S1) and PPARγ2 O-GlcNAc sites (Table S2).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig4-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Raw uncropped images for panel G.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig4-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>Pdgra</italic><sup>+</sup><italic>Vcam1</italic><sup>+</sup> cells as adipogenic progenitors.</title><p>Single-cell expression of <italic>Pdgfra</italic>, <italic>Vcam1</italic>, <italic>Lepr</italic>, <italic>Adipoq</italic>, and <italic>Ly6a</italic> genes in mouse BMSCs published by Baryawno et al. (<bold>A</bold>) and Zhong et al. (<bold>B</bold>) Data were visualized and plotted at Single Cell Portal (<ext-link ext-link-type="uri" xlink:href="https://singlecell.broadinstitute.org/single_cell">https://singlecell.broadinstitute.org/single_cell</ext-link>). Note that <italic>Ly6a</italic> (encoding Sca-1) marks more primitive mesenchymal stem cells, while <italic>Pdgfra</italic>, <italic>Vcam1</italic>, <italic>Lepr</italic>, and <italic>Adipoq</italic> collectively label the determined adipogenic precursors.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw uncropped images for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig4-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>RUNX2 inhibits adipogenesis independently of O-GlcNAcylation.</title><p>C3H10T1/2 cells were infected with lentiviruses expressing WT- or O-GlcNAc-deficient (3SA)- RUNX2, then induced for adipogenic differentiation. Adipogenesis was quantified by Oil Red O staining (<bold>A</bold>) and Perilipin western blotting (<bold>B</bold>). Data are presented as mean ± SEM. ***, p&lt;0.01 by one-way ANOVA.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>PPARγ2 O-GlcNAcylation is required for adipogenesis.</title><p>(<bold>A</bold>) PPARγ2 protein domains with the O-GlcNAc site shown in red. (P)hosphorylation, (SUMO)lation and (Ac)etylation sites were also shown. (<bold>B</bold>) Previously known (T84) and newly identified (S104, S133, S370, and T487) O-GlcNAc sites were mutated to alanine separately (T84A and 4A, respectively) or together (5A). PPRE-luciferase assay of PPARγ2 was performed. Data are presented as mean ± SEM. ***, p&lt;0.01 by one-way ANOVA. (<bold>C</bold>) C3H10T1/2 cells were infected with lentiviral PPARγ2, induced to become adipocytes in the presence of only insulin, and stain with Oil Red O.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig4-figsupp3-v2.tif"/></fig></fig-group><p>We went on to determine the O-GlcNAc targets of OGT in suppressing adipogenesis. As an osteogenic regulator, RUNX2 also reciprocally suppresses the adipogenic program (<xref ref-type="bibr" rid="bib2">Ahrends et al., 2014</xref>). However, such suppression was not dependent on O-GlcNAcylation, because O-GlcNAc-deficient RUNX2 displayed similar efficiency as the wildtype protein to reduce lipid deposition and perilipin expression in differentiated C3H10T1/2 cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). It is possible that O-GlcNAc on RUNX2 selectively facilitates the recruitment of transcriptional co-activators for osteogenesis but does not suppress the chromatin remodeling needed for the activation of adipogenic transcriptional factors.</p><p>PPARγ1 is O-GlcNAcylated at T54 in the A/B activation domain (<xref ref-type="bibr" rid="bib31">Ji et al., 2012</xref>), corresponding to T84 in PPARγ2, the major isoform in adipocytes (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A</xref>). Mutating T84 in PPARγ2 did not ablate the ability of the OGA inhibitor TMG to suppress adipogenesis in C3H10T1/2 cells (data not shown), suggesting the existence of other unidentified O-GlcNAc sites on PPARγ2 or other target proteins than PPARγ2. Through mass spectrometry, we were able to map four additional O-GlcNAc sites on PPARγ2 (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Intriguingly, mutating these four sites or together with T84 to alanine, render PPARγ2 incompetent to induce transcription and adipogenesis (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B, C</xref>). It suggests that PPARγ2 O-GlcNAcylation is essential for adipocyte maturation, but likely does not mediate the anti-adipogenic effect of OGT in perinatal BMSCs.</p><p>We then looked to C/EBPβ, an early transcription factor that specifies the adipogenic fate of BMSCs (<xref ref-type="bibr" rid="bib12">Cao et al., 1991</xref>; <xref ref-type="bibr" rid="bib17">Darlington et al., 1998</xref>). It has been reported that OGT modifies C/EBPβ to inhibit its transcriptional activity (<xref ref-type="bibr" rid="bib38">Li et al., 2009</xref>; <xref ref-type="bibr" rid="bib51">Qian et al., 2018</xref>). As expected, ablating O-GlcNAcylation of C/EBPβ (2A mutation) promotes adipogenic differentiation of C3H10T1/2 cells (<xref ref-type="fig" rid="fig4">Figure 4J and K</xref>). Taken together, we concluded that, by O-GlcNAcylating and reciprocally regulating RUNX2 and C/EBPβ, OGT is required for the proper allocation of skeletal progenitors into osteogenic versus adipogenic lineages during development.</p></sec><sec id="s2-4"><title>OGT deficiency disrupts the BM niche</title><p>Skeletal development is concomitant with the establishment of definitive hematopoiesis in the BM. To test if OGT deficiency affects the niche function of <italic>Sp7</italic><sup>+</sup> cells for B-cell lymphopoiesis, we performed flow cytometry analyses of bone marrow of 4-week-old mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>; <xref ref-type="bibr" rid="bib26">Hardy et al., 1991</xref>). No changes in the percentage of lineage<sup>-</sup>Sca-1<sup>+</sup>Kit<sup>+</sup> (LSK) progenitor cells, common lymphoid progenitors (CLPs), Fraction A that contains pre-pro-B cells were observed between control and <italic>Ogt</italic> cKO mice (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>). While frequencies of Fraction B and C pro-B, pre-B, and immature B in <italic>Ogt</italic> cKO mice were drastically reduced (<xref ref-type="fig" rid="fig5">Figure 5E–I</xref>), demonstrating a developmental blockage from pre-pro-B to pro-B cells. In the peripheral blood, there was specific loss of CD19<sup>+</sup>B220<sup>+</sup> B cells but not CD4<sup>+</sup> or CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig5">Figure 5J–L</xref>). B-cell dysfunction observed here was similar to the phenotype in mice when all <italic>Sp7</italic><sup>+</sup> cells were depleted (<xref ref-type="bibr" rid="bib69">Yu et al., 2016</xref>) or IL-7 was deleted in BMSCs (<xref ref-type="bibr" rid="bib16">Cordeiro Gomes et al., 2016</xref>), indicating that O-GlcNAcylation is essential for the <italic>Sp7</italic><sup>+</sup> lineage cells to establish a niche environment for B-cell lymphopoiesis.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Impaired B lymphopoiesis and myeloid skewing in <italic>Ogt</italic> cKO mice.</title><p>(<bold>A</bold>) Schematic view of B cell development in the BM and blockade by stromal OGT deficiency (red X). (<bold>B–C</bold>) Flow cytometric quantification of LSK (<bold>B</bold>) and CLP (<bold>C</bold>) among live BM cells (n=4–6). (<bold>D–I</bold>) Flow cytometric quantification of fraction A (<bold>D</bold>), fraction B (<bold>E</bold>), fraction C (<bold>F</bold>), fraction C’ (<bold>G</bold>), fraction D (<bold>H</bold>), and immature B (<bold>I</bold>) frequencies among live BM lymphocytes (n=6–7). (<bold>J–L</bold>) Flow cytometric quantification of B220<sup>+</sup> B cell (<bold>J</bold>), CD4<sup>+</sup> T cell (<bold>K</bold>), and CD8<sup>+</sup> T cell (<bold>L</bold>) percentages in the blood (n=3–4). (<bold>M, N</bold>) CMP/CLP ratio (<bold>M</bold>) and GMP/EMP ratio (<bold>N</bold>) in the BM (n=6–7). (<bold>O, P</bold>) Complete blood counting showing numbers of RBC (<bold>O</bold>) and neutrophil (<bold>P</bold>) (n=7–9). Data are presented as mean ± SEM. *, p&lt;0.05; **, p&lt;0.01; and ***, p&lt;0.001 by unpaired student’s t-test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Antibodies used for flow cytometry.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig5-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Flow cytometry of BM B cells.</title><p>(<bold>A</bold>) B cell lineage development and surface markers used for flow cytometry. (<bold>B</bold>) Gating strategy for B cell populations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig5-figsupp1-v2.tif"/></fig></fig-group><p>BM adiposity is associated with myeloid overproduction in conditions including aging, irradiation (<xref ref-type="bibr" rid="bib28">Ho et al., 2019</xref>), osteopenia (<xref ref-type="bibr" rid="bib32">Kajkenova et al., 1997</xref>), and obesity (<xref ref-type="bibr" rid="bib61">Singer et al., 2014</xref>), indicating the supportive function of marrow adipocytes on demand-adapted myelopoiesis. Consistently with the increased BM adiposity found in <italic>Ogt</italic> cKO mice, we also observed biased HSPC differentiation toward the myeloid lineage, as shown by increased ratio of common myeloid progenitor (CMP) to common lymphoid progenitors (CLPs) and ratio of granulocyte-monocyte progenitors (GMP) to megakaryocyte-erythrocyte progenitors (MEP) in the BM (<xref ref-type="fig" rid="fig5">Figure 5M and N</xref>). As a result, increased numbers of red blood cells and neutrophils were observed in the blood of <italic>Ogt</italic> cKO mice (<xref ref-type="fig" rid="fig5">Figure 5O and P</xref>). Together, these results demonstrate that OGT deficiency in neonatal BMSCs establishes a BM environment that promotes myelopoiesis and simultaneously impairs B cell development.</p></sec><sec id="s2-5"><title>Transcriptional regulation of niche cytokines by RUNX2 and C/EBPβ O-GlcNAcylation</title><p>BMSC-derived SCF (encoded by the <italic>Kitl</italic> gene) and IL-7 are required for the myeloid differentiation and B-cell development, respectively (<xref ref-type="bibr" rid="bib6">Asada et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Cordeiro Gomes et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Ding et al., 2012</xref>). We sought to test if their expression is controlled by the same transcriptional network determining BMSC fate. Adipogenic differentiation of mesenchymal C3H10T1/2 cells concomitantly increased <italic>Kitl</italic> while decreased <italic>Il7</italic> gene expression (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). Simultaneous treatment with the OGT inhibitor OSMI-1 dampened <italic>Il7</italic> expression before differentiation but enhanced <italic>Kitl</italic> expression in differentiated adipocytes (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). On the other hand, osteogenic differentiation suppressed <italic>Kitl</italic> transcription, which could be further inhibited by TMG that elevated global O-GlcNAcylation (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). While <italic>Il7</italic> mRNA levels were not evidently affected by osteogenic differentiation, TMG stimulated its expression (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). O-GlcNAcylation inhibits the adipogenesis specified by C/EBPβ but supports osteogenesis determined by RUNX2. In concert, C/EBPβ overexpression in C3H10T1/2 cells activated <italic>Kitl</italic> transcription and suppressed <italic>Il7</italic> expression, which was further exacerbated by O-GlcNAc-deficient C/EBPβ (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). However, RUNX2 overexpression decreased <italic>Kitl</italic> mRNA levels (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). When compared to the wildtype, O-GlcNAc-defective RUNX2 was impaired in inducing <italic>Il7</italic> expression (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Collectively, these results reveal that protein O-GlcNAcylation, by acting on BMSC lineage transcriptional factors, establishes a pro-lymphopoietic niche during neonatal bone development and at the same time prevents the myeloid-skewing, adipogenic BM environment.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>O-GlcNAc regulation of niche cytokine expression.</title><p>(<bold>A, B</bold>) C3H10T1/2 cells were treated with vehicle or OGT inhibitor OSMI and differentiated for adipocytes (n=4). <italic>Kitl</italic> (<bold>A</bold>) and <italic>Il7</italic> (<bold>B</bold>) gene expression was determined by RT-qPCR. (<bold>C, D</bold>) C3H10T1/2 cells were treated with vehicle or OGA inhibitor TMG and induced for osteogenic differentiation (n=6). <italic>Kitl</italic> (<bold>C</bold>) and <italic>Il7</italic> (<bold>D</bold>) gene expression was determined by RT-qPCR. (<bold>E–H</bold>) C3H10T1/2 cells were infected with lentiviruses expressing WT and O-GlcNAc-deficient C/EBPβ (<bold>E, F</bold>) or RUNX2 (<bold>G, H</bold>). Expression <italic>Kitl</italic> (<bold>E, G</bold>) and <italic>Il7</italic> (<bold>F, H</bold>) was measured by RT-qPCR (n=6). (<bold>I</bold>) Proposed action of protein O-GlcNAcylation in regulating the BMSC niche function. Data are presented as mean ± SEM. *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001 by two-way ANOVA (<bold>A–D</bold>) and one-way ANOVA (<bold>E–H</bold>).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Sequences of oligos used for RT-qPCR.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-85464-fig6-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig6-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Post-translational modification networks exist in the bone-BM organ to regulate its development and remodeling. Given that definitive hematopoiesis is matured in perinatal BM, it is tempting to hypothesize that the regulatory mechanisms guiding the development of bone also establish the BM niche for hematopoiesis. However, experimental evidence has been largely lacking so far. In the present study, we examined the vital role of the under-studied protein O-GlcNAcylation in determining the osteogenic versus adipogenic fate specification of BMSCs and in balancing the pro-lymphopoietic and pro-myelopoietic niche function of BMSCs. We showed that, by modifying and reciprocally regulating RUNX2 and C/EBPβ, O-GlcNAc orchestrates the early development of skeletal and hematopoietic systems (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Working model of O-GlcNAc signaling in bone-BM development.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-fig7-v2.tif"/></fig><p>Multiple temporally and spatially distinct types of progenitors contribute to bone development and maintenance. In the early embryo, <italic>Sp7</italic><sup>+</sup> progenitors give rise to fetal bone tissues and transient stromal cells that disappear in early postnatal life (<xref ref-type="bibr" rid="bib44">Mizoguchi et al., 2014</xref>). Perinatally, <italic>Sp7</italic><sup>+</sup> progenitors contribute to osteolineage cells and long-lived perivascular BMSCs that can be labeled by leptin receptor (<italic>Lepr</italic>) and adiponectin (<italic>Adipoq</italic>) (<xref ref-type="bibr" rid="bib74">Zhong et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Zhou et al., 2017</xref>). Recent evidence suggests that a significant portion of adult BMSCs and osteoblasts originate from collagen II (<italic>Col2</italic>)- and aggrecan (<italic>Acan</italic>)-expressing chondrocytes (<xref ref-type="bibr" rid="bib48">Ono et al., 2014</xref>). Due to the fact that <italic>Sp7<sup>GFP:Cre</sup></italic> targets osteoblasts, BMSCs, and a subset of chondrocytes (<xref ref-type="bibr" rid="bib14">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2013</xref>), the current study could not delineate the exact developmental stages and the primary cellular compartments where OGT instructs bone development. Nonetheless, our ex vivo experiments and adult-onset targeting of OGT in <italic>Sp7</italic><sup>+</sup> osteoblasts, together with prior published in vivo and in vitro evidence (<xref ref-type="bibr" rid="bib5">Andrés-Bergós et al., 2012</xref>; <xref ref-type="bibr" rid="bib47">Nagel and Ball, 2014</xref>; <xref ref-type="bibr" rid="bib46">Nagel et al., 2013</xref>), certainly reveal the indispensability of protein O-GlcNAcylation for chondro-osteogenic differentiation. While this study primarily focused early life bone development, it is warranted to further investigate the role of OGT in the transition to appositional remodeling during adulthood (<xref ref-type="bibr" rid="bib60">Shu et al., 2021</xref>) and in osteoporosis pathogenesis during aging. Moreover, bone-forming skeletal stem cells (SSCs) are identified in other anatomical regions of long bones, such as growth plate, periosteum, and endosteum (<xref ref-type="bibr" rid="bib4">Ambrosi et al., 2019</xref>). It remains undetermined whether O-GlcNAcylation is abundant in and controls the development and function of these SSC populations.</p><p>O-GlcNAcylation is required for PPARγ to drive adipogenesis, but why did not OGT-deficient BMSCs arrest their differentiation after being committed to the adipogenic lineage. One speculation is that PPARγ O-GlcNAcylation is extremely low in homeostatic conditions, which might help explain the rare appearance of adipocytes in young BM. If so, the loss of PPARγ O-GlcNAcylation in <italic>Ogt</italic> cKO mice would not block adipogenesis. Second, the differentiation of marrow adipose tissue (MAT) is distinct from peripheral white adipose tissue (WAT). For instance, adipogenic BMSCs in adult mice already express large amount of <italic>Adipoq</italic>, which is only present in mature WAT adipocytes. Certain forms of genetic lipodystrophy (e.g. mutations in <italic>CAV1</italic> and <italic>PTRF</italic>) selectively lose peripheral WAT but preserve MAT (<xref ref-type="bibr" rid="bib58">Scheller et al., 2015</xref>). These findings suggest that MAT might be less dependent on PPARγ or able to adopt alternative differentiation when PPARγ is absent or inhibited. In fact, a recent publication reported a secondary adipogenic pathway in lipodystrophic 'fat-free' mice (<xref ref-type="bibr" rid="bib71">Zhang et al., 2021</xref>). Lastly, our preliminary examination of old <italic>Ogt</italic> cKO mice revealed the resolution of BM adiposity, indicating that PPARγ and its O-GlcNAc modification become essential for the adipogenic differentiation of adult BMSCs.</p><p>Protein O-GlcNAcylation senses glucose availability (<xref ref-type="bibr" rid="bib25">Hardivillé and Hart, 2014</xref>; <xref ref-type="bibr" rid="bib53">Ruan et al., 2012</xref>), hormonal cues (<xref ref-type="bibr" rid="bib56">Ruan et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Ruan et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Whelan et al., 2008</xref>), cellular stress (<xref ref-type="bibr" rid="bib43">Martinez et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Ruan et al., 2017</xref>), and immune signals (<xref ref-type="bibr" rid="bib13">Chang et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="bib72">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Zhao et al., 2022</xref>) to maintain cellular and tissue homeostasis. Osteogenic differentiation of mesenchymal cells induces global O-GlcNAc levels (<xref ref-type="bibr" rid="bib33">Kim et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Nagel and Ball, 2014</xref>); however, the upstream mechanistic regulators of osteoblastic O-GlcNAcylation remain enigmatic. High glucose has been shown to promote O-GlcNAcylation and osteogenic differentiation of cartilage endplate stem cells (<xref ref-type="bibr" rid="bib62">Sun et al., 2019</xref>). BMSCs preferentially use glycolysis for bioenergetics to support their self-renewal and multipotency (<xref ref-type="bibr" rid="bib30">Ito and Suda, 2014</xref>; <xref ref-type="bibr" rid="bib64">van Gastel and Carmeliet, 2021</xref>). Active aerobic glycolysis also fuels the high anabolic demand during bone formation. It would be important in the future to determine whether flux of the hexosamine biosynthetic pathway, a branch of glycolysis (<xref ref-type="bibr" rid="bib55">Ruan et al., 2013b</xref>), increases to provide more UDP-GlcNAc for O-GlcNAc modification. We also showed here that PTH treatment increased protein O-GlcNAcylation. Signaling through the PTH receptor activates the cAMP-protein kinase A (PKA)-CREB pathway and the accumulation of inositol trisphosphate (IP3) and diacylglycerol (DAG), which further increase intracellular Ca<sup>2+</sup> and PKC, respectively (<xref ref-type="bibr" rid="bib18">Datta and Abou-Samra, 2009</xref>). Future experiments are required to determine if OGT enzymatic activity can be regulated by these signaling nodes, for example Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) (<xref ref-type="bibr" rid="bib57">Ruan et al., 2017</xref>). Sex differences in skeletal development, maintenance, and aging have been well appreciated. Whether BMSC O-GlcNAc signaling is differentially regulated between male and female animals, particularly during puberty and aging, is an important question that remains unaddressed. Since only male mice were investigated in the current study, it is unclear if the reciprocal regulation of RUNX2 and PPARγ by O-GlcNAcylation in determining the bone-fat balance is equally vital in females.</p><p>The BM microenvironment, composed of BMSCs, osteoblasts, adipocytes, sympathetic nerves, and vascular endothelial cells, has been highlighted as an important extrinsic factor for the maintenance and differentiation of distinct hematopoietic lineage progenitors (<xref ref-type="bibr" rid="bib9">Bianco and Robey, 2015</xref>; <xref ref-type="bibr" rid="bib11">Calvi and Link, 2015</xref>; <xref ref-type="bibr" rid="bib45">Morrison and Scadden, 2014</xref>; <xref ref-type="bibr" rid="bib66">Wei and Frenette, 2018</xref>). While the concomitant development, remodeling, and aging of the skeletal and hematopoietic systems have been observed in various pathophysiological conditions, mechanisms underlying the coordinated regulation of the two systems are less understood. Our current study has provided the first evidence that RUNX2, permitted by O-GlcNAcylation, not only is indispensable for the osteoblast development, but also establishes the endosteal niche for B lymphocytes by driving IL-7 expression (<xref ref-type="fig" rid="fig7">Figure 7</xref>). When OGT is deficient, the perivascular BMSCs are prone to adipogenic differentiation, which also activates C/EBPβ-dependent SCF expression and myelopoiesis. During aging, the parallel dysfunction of the skeletal and hematopoietic systems leads to osteoporosis, marrow fat accumulation, and myeloid hematopoietic skewing (<xref ref-type="bibr" rid="bib23">Geiger et al., 2013</xref>). Whether BMSC aging is associated with O-GlcNAc decline and whether the balance between RUNX and C/EBPβ leads to bone-fat imbalances and niche dysfunction require future investigations.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent<break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Sp7<sup>GFP:Cre</sup></italic> (<italic>B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J</italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:006361">IMSR_JAX:006361</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent<break/>(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Ogt<sup>fl/fl</sup></italic> (<italic>B6.129-Ogttm1Gwh/J</italic>)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:004860">IMSR_JAX:004860</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Primary BMSC</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">From long bones of mouse</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C3H10T1/2</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CCL-226</td><td align="left" valign="bottom">Verified by ATCC and tested negative for mycoplasma</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HEK293FT</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">R70007</td><td align="left" valign="bottom">Verified by Invitrogen and tested negative for mycoplasma</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Cercopithecus aethiops</italic>)</td><td align="left" valign="bottom">COS7</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-1651</td><td align="left" valign="bottom">Verified by ATCC and tested negative for mycoplasma</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="char" char="hyphen" valign="bottom">6xOSE2-luc</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Phimphilai et al., 2006</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Renilla reniformis</italic>)</td><td align="left" valign="bottom">pGL4-hRluc</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">#E688A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">PPREx3-TK-luc</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">#1015</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Perilipin<break/>(Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">9349T</td><td align="left" valign="bottom">IF(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-B220 (Rat monoclonal)</td><td align="left" valign="bottom">Life Technologies</td><td align="char" char="hyphen" valign="bottom">67-0452-82</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD43<break/>(Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">553271</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD24 (Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">101822</td><td align="left" valign="bottom">FC(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ly-51 (Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">108305</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD127 (Rat monoclonal)</td><td align="left" valign="bottom">Tonbo Biosciences</td><td align="char" char="ndash" valign="bottom">20–1271 U100</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD25 (Rat monoclonal)</td><td align="left" valign="bottom">Life Technologies</td><td align="char" char="hyphen" valign="bottom">63-0251-82</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD19<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">115545</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Biotin-conjugated lineage antibodies<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">133307</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD4<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">100403</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD5<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">100603</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD8<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">100703</td><td align="left" valign="bottom">FC(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD127-APC<break/>(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">17-1271-82</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-c-Kit-APC-eFluor780<break/>(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">47-1171-82</td><td align="left" valign="bottom">FC(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sca-1-Super Bright 436<break/>(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">62-5981-82</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD34-PE<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">152204</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FcγR-PerCP-eFluor710<break/>(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">46-0161-80</td><td align="left" valign="bottom">FC(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD150-BV605<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">115927</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD48-BUV395<break/>(Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">740236</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD45-BUV395<break/>(Rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">564279</td><td align="left" valign="bottom">FC(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ter119-BV421<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">116234</td><td align="left" valign="bottom">FC(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD31-BV421<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">102424</td><td align="left" valign="bottom">FC(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PDGFRa-Super Bright 600<break/>(Rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="char" char="hyphen" valign="bottom">63-1401-82</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-VCAM1-PE<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="char" char="." valign="bottom">105713</td><td align="left" valign="bottom">FC(1:100)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">RUNX2-WT</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLV-EF1a-RUNX2-WT-IRES-Hygro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">RUNX2-3A/ RUNX2-3SA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLV-EF1a-RUNX2-3Mut-IRES-Hygro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PPARλ2-WT</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLVX- PPARλ2-WT-Puro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PPARλ2-T84A</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLVX- PPARλ2-T84A-Puro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PPARλ2-4A</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLVX- PPARλ2-4A-Puro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PPARλ2-5A</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pLVX- PPARλ2-5A-Puro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">C/EBPβ-WT</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pCDH-CMV-Cebpb-WT-P2a-Puro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">C/EBPβ–2A</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pCDH-CMV-Cebpb-2MUT-P2a-Puro</td><td align="left" valign="bottom">See Methods; available upon request</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Q5 Site-Directed Mutagenesis Kit</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">#E0554</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Dual-Luciferase Assay System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E1910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Transporter 5 Transfection Reagent</td><td align="left" valign="bottom">Polysciences</td><td align="char" char="ndash" valign="bottom">26008–1 A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Parathyroid hormone (PTH)</td><td align="left" valign="bottom">Genscript</td><td align="left" valign="bottom">RP01001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">OSMI-1</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">SML1621-5MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Thiamet-G (TMG)</td><td align="left" valign="bottom">Biosynth</td><td align="left" valign="bottom">MD08856</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Doxycycline food</td><td align="left" valign="bottom">Bio-Serv</td><td align="left" valign="bottom">S3888</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">IBMX</td><td align="left" valign="bottom">CAYMAN</td><td align="char" char="." valign="bottom">13347</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dexamethasone</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">D4902</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Insulin</td><td align="left" valign="bottom">Sigma</td><td align="char" char="." valign="bottom">91077 C</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Rosiglitazone</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">R2408-10MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ascorbic acid</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">A4403-100MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">β-Glycerophosphate</td><td align="left" valign="bottom">Santa cruz</td><td align="left" valign="bottom">sc-220452</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJ</td><td align="left" valign="bottom">BD Life Sciences</td><td align="left" valign="bottom">V10</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>All animal experiments were approved by the institutional animal care and use committee of the University of Minnesota (protocol # 2112–39682 A). All the mice were group-housed in light/dark cycle- (6am-8pm light), temperature- (21.5 ± 1.5 °C), and humidity-controlled (30–70%) room, and had free access to water and regular chow (Teklad #2018) unless otherwise indicated. Moist food was provided to constitutive <italic>Sp7<sup>GFP:Cre</sup></italic> animals to circumvent tooth defects and prevent malnutrition. All mice were maintained on a C57BL6 background. Due to the X-chromosome localization of the <italic>Ogt</italic> gene, only male mice were used in the study if not specified in the text or figures. To suppress Cre activity, designated breeders were fed a diet containing 200 mg/kg doxycycline (Bio-serv, S3888).</p></sec><sec id="s4-2"><title>BMSC isolation, culture, and differentiation</title><p>BMSC were isolated from the long bones as described previously (<xref ref-type="bibr" rid="bib76">Zhu et al., 2010</xref>). The fragments of long bones were digested with collagenase II for 30 min. The released cells were discarded, and the digested bone fragments were cultivated in the BMSCs growth medium (alpha-MEM supplemented with 10% FBS). Once confluent, cells were switched to either adipogenic differentiation medium (alpha-MEM supplemented with 20% FBS, 500 µM IBMX, 1 µM Dexamethasone, 10 µg/ml Insulin and 1 µM Rosiglitazone) for the first 2 days. The medium was then changed to adipocyte differentiation base medium (α-MEM supplemented with 20% FBS, 10 µg/ml Insulin and 1 µM Rosiglitazone) for the next 4 days followed by oil red O staining. For osteogenic differentiation, cells were induced with osteoblast differentiation medium (α-MEM supplemented with 10% FBS, 0.3 mM ascorbic acid, 10 mM β-glycerophosphate, 0.1 µM Dexamethasone) for 14 days followed by ALP staining or for 28 days followed by Alizarin red staining.</p></sec><sec id="s4-3"><title>Cell culture, plasmids, and lentiviruses</title><p>HEK 293, COS7, and C3H10T1/2 (ATCC, CCL-226) cells were cultured with DMEM plus 10% of FBS. The mouse RUNX2-Myc/DDK plasmid was purchased from OriGene (MR227321), then subcloned into pLV-EF1a-IRES-Hygro (Addgene #85134). Mouse PPARγ2 with a N-terminal MYC tag was subcloned into pLVX-Dsred-puro plasmid. C/EBPβ plasmids were kindly provided by Dr. Xiaoyong Yang at Yale University and then subcloned into pCDH-CMV-P2a-Puro. O-GlcNAc sites were mutated into alanine with Q5 Site-Directed Mutagenesis Kit (NEB#E0554). Lentivirus was packed as previously described (<xref ref-type="bibr" rid="bib29">Huang et al., 2022</xref>). Briefly, 293 FT cells were transfected with over-expression plasmids pSPAX2, and pMD2.G. Media with lentivirus were filtered and added into C3H10T1/2 cells. Seventy-two hr after infection, cells were then selected with drugs according to the resistance genes they possessed.</p></sec><sec id="s4-4"><title>Luciferase assay</title><p>For Runx2 luciferase assay, empty or RUNX2 vectors were transfected into COS7 cells with Lipofectamine, together with 6xOSE2-luc (<xref ref-type="bibr" rid="bib50">Phimphilai et al., 2006</xref>) and pGL4-hRluc vectors in which either firefly or Renilla luciferase genes were expressed under the control of the RUNX2-specific or the constitutive SV40 promoter, respectively. After 6 hr, cells were washed three times and with the addition of 50 µM OSMI-1. Cells were incubated for an additional 48 hr in growth medium containing 5% serum. Luminescent signals were generated using the Dual-Luciferase Assay System (Promega). Relative light units (RLU) for the 6xOSE2 reporter were normalized against pGL4-hRLuc values as an internal control for transfection efficiency. For PPARγ2 luciferase assays, C3H10T1/2 cells were transfected with Transporter 5 Transfection Reagent (Polysciences) following manufacture’s protocol. PPARγ2 transcriptional activity was determined using the PPREx3-TK-luc reporter (Addgene, #1015).</p></sec><sec id="s4-5"><title>Histology</title><p>Bone tissues were fixed in formalin solution at 4 °C for 24 hr. Tissue embedding, sectioning, and hematoxylin and eosin staining were performed at the Comparative Pathology Shared Resource of the University of Minnesota. For immunostaining, the tissues were embedded in OCT then cut into 7 µm slides. After three times of PBS wash, the slides were incubated with blocking buffer (3% BSA in PBS) for 1 hr, then immersed with anti-Perilipin (Cell Signaling Technology, #9349) antibody overnight at 4 °C. For immunofluorescence, PBS-washed slides were incubated with a fluorescent secondary antibody at room temperature for 1 hr, and then mounted with VECTASHIELD Antifade Mounting Medium with DAPI after three times of PBS wash. A Nikon system was used for imaging. Goldner’s trichrome and Safranin O staining were performed at Servicebio, China.</p></sec><sec id="s4-6"><title>micro-CT</title><p>The samples were scanned with an in vitro micro-CT device (Skyscan 1272, Bruker micro-CT) with scanning parameters of: Source Voltage = 60 kV, Source Current = 166 µA, exposure 897ms/frame, average of 3 frames per projection, Rotation Step (deg)=0.200 and 0.25 mm Aluminum filter. The specimens were scanned at high resolution (2016×1344 pixels) with an Isotropic voxel size of 7.1 μm. Reconstructions for X-ray projections and re-alignment were performed using the Skyscan software (NRecon and DataViewer) (v. 1.7.3.1, Brüker micro-CT, Kontich, Belgium). Ring artefact and beam hardening corrections were applied in reconstruction. Datasets were loaded into SkyScan CT-Analyzer software for measurement of BMD. Calibration was performed with 0.25- and 0.75 mg/mL hydroxyapatite mice phantoms provided by SkyScan. For cancellous and cortical bone analysis, the scanning regions were confined to the distal metaphysis, 100 slices starting at 0.5 mm proximally from the proximal tip of the primary spongiosa for the cancellous portion and 100 slices starting at 4.5 mm proximally from the center of intercondylar fossa for the cortical portion.</p></sec><sec id="s4-7"><title>O-GlcNAc mass spectrometry</title><p>Myc-tagged PPARγ2 was co-transfected with OGT into 15 cm-dishes of 293T cells and purified by immunoprecipitation with anti-c-Myc agarose beads (Pierce), followed by PAGE gel electrophoresis. The corresponding PPARγ2 band was cut for in gel Trypsin (Promega) digestion. Tryptic peptides were analyzed by on-line LC-MS/MS using an Orbitrap Fusion Lumos (Thermo) coupled with a NanoAcquity UPLC system (Waters) as we previously reported (<xref ref-type="bibr" rid="bib41">Liu et al., 2019</xref>; <xref ref-type="bibr" rid="bib73">Zhao et al., 2022</xref>). Peaklists were generated using PAVA (UCSF) and searched using Protein Prospector 5.23.0 against the SwissProt database and a randomized concatenated database with the addition of the recombinant PPARγ2 sequence. HexNAcylated peptides were manually verified.</p></sec><sec id="s4-8"><title>Real-time RT-PCR</title><p>RNA was isolated with Trizol and reverse transcribed into cDNA with the iScript cDNA Synthesis Kit. Real-time RT-PCR was performed using iTaq Universal SYBR Green Supermix and gene-specific primers (<xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>) on a Bio-Rad C1000 Thermal Cycler.</p></sec><sec id="s4-9"><title>Flow cytometry</title><p>For PDGFRa+VCAM1+preadipocytes, BM cells were stained with anti-CD45, anti-Ter119, anti-CD31, anti-PDGFRa, and anti-VCAM1. We gated the PDGFRa+VCAM1+ cells after excluding the CD45+Ter119+CD31+ cells. For B-cell lymphopoiesis, BM cells were stained in PBS containing 1% (w/v) bovine serum albumin on ice for 30 min, with anti-B220 (Life Technologies, 67-0452-82), anti-CD43 (BD Biosciences, 553271), anti-CD24 (Biolegend, 101822), anti-Ly-51 (Biolegend, 108305), anti-CD127 (Tonbo Biosciences, 20–1271 U100), anti-CD25 (Life Technologies, 63-0251-82) and anti-CD19 (Biolegend, 115545). For hematopoietic stem and progenitor cells, BM cells were stained with a cocktail of biotin-conjugated lineage antibodies CD3e, B220, Ter119, Mac-1 and Gr-1 (Biolegend, 133307), CD4 (Biolegend, 100403), CD5 (Biolegend, 100603), CD8 (Biolegend, 100703), followed by Streptavidin-AF488 (Biolegend, 405235). Cells were then stained with CD127-APC (eBioscience, 17-1271-82), c-Kit-APC-eFluor780 (eBioscience, 47-1171-82), Sca-1-Super Bright 436 (eBioscience, 62-5981-82), CD34-PE (Biolegend, 152204) and FcγR-PerCP-eFluor710 (eBioscience, 46-0161-80), CD150-BV605 (Biolegend, 115927), and CD48-BUV395 (BDBioscience, 740236). Fixable Viability Dye was used to exclude dead cells as instructed by the manufacturer. A complete list of used antibodies was shown in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>. Flow cytometry was performed on an LSR Fortessa H0081 or X20 and analyzed with FlowJo.</p></sec><sec id="s4-10"><title>Quantification and statistical analysis</title><p>Results are shown as mean ± SEM. N values (biological replicates) and statistical analysis methods are described in figure legends. The statistical comparisons were carried out using two-tailed unpaired Student’s t-test and one-way or two-way ANOVA with indicated post hoc tests with Prism 9 (Graphpad). Differences were considered significant when p&lt;0.05; *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Funding acquisition, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con9"><p>Supervision, Funding acquisition, Investigation</p></fn><fn fn-type="con" id="con10"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments were approved by the institutional animal care and use committee of the University of Minnesota (protocol # 2112-39682A).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85464-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file. Supplementary tables have been provided for Mass spectrometry, primer sequences, and antibody list.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Xiaoyong Yang for kindly providing wildtype and mutant C/EBPβ plasmids; Dr. Renny Franchesci for providing the 6xOSE2-luc plasmid; and Alexis Nagel for Runx2 luciferase assay. This work was supported by the National Natural Science Foundation of China, China (32170847) to ZH, NIH/NIAID (R01 AI162678) to HZ, the Miriam and Sheldon G Adelson Medical Research Foundation to JCM and ALB, and NIH/NIAID (R01 AI139420 and R01 AI162791) to H-BR.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaron</surname><given-names>N</given-names></name><name><surname>Kraakman</surname><given-names>MJ</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Costa</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Hirakawa</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Lo</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Rosen</surname><given-names>CJ</given-names></name><name><surname>Qiang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells</article-title><source>eLife</source><volume>10</volume><elocation-id>e69209</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.69209</pub-id><pub-id pub-id-type="pmid">34155972</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahrends</surname><given-names>R</given-names></name><name><surname>Ota</surname><given-names>A</given-names></name><name><surname>Kovary</surname><given-names>KM</given-names></name><name><surname>Kudo</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>BO</given-names></name><name><surname>Teruel</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Controlling low rates of cell differentiation through noise and ultrahigh feedback</article-title><source>Science</source><volume>344</volume><fpage>1384</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1126/science.1252079</pub-id><pub-id pub-id-type="pmid">24948735</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname><given-names>TH</given-names></name><name><surname>Scialdone</surname><given-names>A</given-names></name><name><surname>Graja</surname><given-names>A</given-names></name><name><surname>Gohlke</surname><given-names>S</given-names></name><name><surname>Jank</surname><given-names>AM</given-names></name><name><surname>Bocian</surname><given-names>C</given-names></name><name><surname>Woelk</surname><given-names>L</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Logan</surname><given-names>DW</given-names></name><name><surname>Schürmann</surname><given-names>A</given-names></name><name><surname>Saraiva</surname><given-names>LR</given-names></name><name><surname>Schulz</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration</article-title><source>Cell Stem Cell</source><volume>20</volume><fpage>771</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2017.02.009</pub-id><pub-id pub-id-type="pmid">28330582</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosi</surname><given-names>TH</given-names></name><name><surname>Longaker</surname><given-names>MT</given-names></name><name><surname>Chan</surname><given-names>CKF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A revised perspective of skeletal stem cell biology</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>7</volume><elocation-id>189</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2019.00189</pub-id><pub-id pub-id-type="pmid">31572721</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrés-Bergós</surname><given-names>J</given-names></name><name><surname>Tardio</surname><given-names>L</given-names></name><name><surname>Larranaga-Vera</surname><given-names>A</given-names></name><name><surname>Gómez</surname><given-names>R</given-names></name><name><surname>Herrero-Beaumont</surname><given-names>G</given-names></name><name><surname>Largo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>33615</fpage><lpage>33628</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.354241</pub-id><pub-id pub-id-type="pmid">22859309</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asada</surname><given-names>N</given-names></name><name><surname>Kunisaki</surname><given-names>Y</given-names></name><name><surname>Pierce</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Fernandez</surname><given-names>NF</given-names></name><name><surname>Birbrair</surname><given-names>A</given-names></name><name><surname>Ma’ayan</surname><given-names>A</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Differential cytokine contributions of perivascular haematopoietic stem cell niches</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>214</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1038/ncb3475</pub-id><pub-id pub-id-type="pmid">28218906</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baryawno</surname><given-names>N</given-names></name><name><surname>Przybylski</surname><given-names>D</given-names></name><name><surname>Kowalczyk</surname><given-names>MS</given-names></name><name><surname>Kfoury</surname><given-names>Y</given-names></name><name><surname>Severe</surname><given-names>N</given-names></name><name><surname>Gustafsson</surname><given-names>K</given-names></name><name><surname>Kokkaliaris</surname><given-names>KD</given-names></name><name><surname>Mercier</surname><given-names>F</given-names></name><name><surname>Tabaka</surname><given-names>M</given-names></name><name><surname>Hofree</surname><given-names>M</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Papazian</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Ashenberg</surname><given-names>O</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Vaishnav</surname><given-names>ED</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia</article-title><source>Cell</source><volume>177</volume><fpage>1915</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.04.040</pub-id><pub-id pub-id-type="pmid">31130381</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethel</surname><given-names>M</given-names></name><name><surname>Chitteti</surname><given-names>BR</given-names></name><name><surname>Srour</surname><given-names>EF</given-names></name><name><surname>Kacena</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis</article-title><source>Current Osteoporosis Reports</source><volume>11</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1007/s11914-013-0135-6</pub-id><pub-id pub-id-type="pmid">23423562</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>P</given-names></name><name><surname>Robey</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Skeletal stem cells</article-title><source>Development</source><volume>142</volume><fpage>1023</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1242/dev.102210</pub-id><pub-id pub-id-type="pmid">25758217</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunmeir</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional regulation of PPARs through post-translational modifications</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>1738</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19061738</pub-id><pub-id pub-id-type="pmid">29895749</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvi</surname><given-names>LM</given-names></name><name><surname>Link</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The hematopoietic stem cell niche in homeostasis and disease</article-title><source>Blood</source><volume>126</volume><fpage>2443</fpage><lpage>2451</lpage><pub-id pub-id-type="doi">10.1182/blood-2015-07-533588</pub-id><pub-id pub-id-type="pmid">26468230</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Umek</surname><given-names>RM</given-names></name><name><surname>McKnight</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells</article-title><source>Genes &amp; Development</source><volume>5</volume><fpage>1538</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1101/gad.5.9.1538</pub-id><pub-id pub-id-type="pmid">1840554</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Weng</surname><given-names>CL</given-names></name><name><surname>Lin</surname><given-names>KI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>O-glcnacylation and its role in the immune system</article-title><source>Journal of Biomedical Science</source><volume>27</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.1186/s12929-020-00648-9</pub-id><pub-id pub-id-type="pmid">32349769</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Regan</surname><given-names>J</given-names></name><name><surname>Karuppaiah</surname><given-names>K</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Long</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Osx-cre targets multiple cell types besides osteoblast lineage in postnatal mice</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e85161</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0085161</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptional programming in arteriosclerotic disease: A multifaceted function of the runx2 (runt-related transcription factor 2)</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>41</volume><fpage>20</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.120.313791</pub-id><pub-id pub-id-type="pmid">33115268</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro Gomes</surname><given-names>A</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Lim</surname><given-names>VY</given-names></name><name><surname>Herndler-Brandstetter</surname><given-names>D</given-names></name><name><surname>Nevius</surname><given-names>E</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Tani-Ichi</surname><given-names>S</given-names></name><name><surname>Schlenner</surname><given-names>S</given-names></name><name><surname>Richie</surname><given-names>E</given-names></name><name><surname>Rodewald</surname><given-names>H-R</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Ikuta</surname><given-names>K</given-names></name><name><surname>Pereira</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hematopoietic stem cell niches produce lineage-instructive signals to control multipotent progenitor differentiation</article-title><source>Immunity</source><volume>45</volume><fpage>1219</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.11.004</pub-id><pub-id pub-id-type="pmid">27913094</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darlington</surname><given-names>GJ</given-names></name><name><surname>Ross</surname><given-names>SE</given-names></name><name><surname>MacDougald</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The role of C/EBP genes in adipocyte differentiation</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>30057</fpage><lpage>30060</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.46.30057</pub-id><pub-id pub-id-type="pmid">9804754</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>NS</given-names></name><name><surname>Abou-Samra</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>PTH and pthrp signaling in osteoblasts</article-title><source>Cellular Signalling</source><volume>21</volume><fpage>1245</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2009.02.012</pub-id><pub-id pub-id-type="pmid">19249350</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Saunders</surname><given-names>TL</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endothelial and perivascular cells maintain haematopoietic stem cells</article-title><source>Nature</source><volume>481</volume><fpage>457</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/nature10783</pub-id><pub-id pub-id-type="pmid">22281595</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolgalev</surname><given-names>I</given-names></name><name><surname>Tikhonova</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Connecting the dots: Resolving the bone marrow niche heterogeneity</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>622519</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.622519</pub-id><pub-id pub-id-type="pmid">33777933</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazeli</surname><given-names>PK</given-names></name><name><surname>Horowitz</surname><given-names>MC</given-names></name><name><surname>MacDougald</surname><given-names>OA</given-names></name><name><surname>Scheller</surname><given-names>EL</given-names></name><name><surname>Rodeheffer</surname><given-names>MS</given-names></name><name><surname>Rosen</surname><given-names>CJ</given-names></name><name><surname>Klibanski</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Marrow fat and bone -- new perspectives</article-title><source>The Journal of Clinical Endocrinology and Metabolism</source><volume>98</volume><fpage>935</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-3634</pub-id><pub-id pub-id-type="pmid">23393168</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fistonich</surname><given-names>C</given-names></name><name><surname>Zehentmeier</surname><given-names>S</given-names></name><name><surname>Bednarski</surname><given-names>JJ</given-names></name><name><surname>Miao</surname><given-names>R</given-names></name><name><surname>Schjerven</surname><given-names>H</given-names></name><name><surname>Sleckman</surname><given-names>BP</given-names></name><name><surname>Pereira</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell circuits between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development</article-title><source>The Journal of Experimental Medicine</source><volume>215</volume><fpage>2586</fpage><lpage>2599</lpage><pub-id pub-id-type="doi">10.1084/jem.20180778</pub-id><pub-id pub-id-type="pmid">30158115</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>H</given-names></name><name><surname>de Haan</surname><given-names>G</given-names></name><name><surname>Florian</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The ageing haematopoietic stem cell compartment</article-title><source>Nature Reviews. Immunology</source><volume>13</volume><fpage>376</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1038/nri3433</pub-id><pub-id pub-id-type="pmid">23584423</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanover</surname><given-names>JA</given-names></name><name><surname>Krause</surname><given-names>MW</given-names></name><name><surname>Love</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bittersweet memories: Linking metabolism to epigenetics through O-GlcNAcylation</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>312</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/nrm3334</pub-id><pub-id pub-id-type="pmid">22522719</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardivillé</surname><given-names>S</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation</article-title><source>Cell Metabolism</source><volume>20</volume><fpage>208</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.07.014</pub-id><pub-id pub-id-type="pmid">25100062</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>RR</given-names></name><name><surname>Carmack</surname><given-names>CE</given-names></name><name><surname>Shinton</surname><given-names>SA</given-names></name><name><surname>Kemp</surname><given-names>JD</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow</article-title><source>The Journal of Experimental Medicine</source><volume>173</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1084/jem.173.5.1213</pub-id><pub-id pub-id-type="pmid">1827140</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>GW</given-names></name><name><surname>Housley</surname><given-names>MP</given-names></name><name><surname>Slawson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins</article-title><source>Nature</source><volume>446</volume><fpage>1017</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1038/nature05815</pub-id><pub-id pub-id-type="pmid">17460662</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>Y-H</given-names></name><name><surname>Del Toro</surname><given-names>R</given-names></name><name><surname>Rivera-Torres</surname><given-names>J</given-names></name><name><surname>Rak</surname><given-names>J</given-names></name><name><surname>Korn</surname><given-names>C</given-names></name><name><surname>García-García</surname><given-names>A</given-names></name><name><surname>Macías</surname><given-names>D</given-names></name><name><surname>González-Gómez</surname><given-names>C</given-names></name><name><surname>Del Monte</surname><given-names>A</given-names></name><name><surname>Wittner</surname><given-names>M</given-names></name><name><surname>Waller</surname><given-names>AK</given-names></name><name><surname>Foster</surname><given-names>HR</given-names></name><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name><name><surname>Nerlov</surname><given-names>C</given-names></name><name><surname>Ghevaert</surname><given-names>C</given-names></name><name><surname>Vainchenker</surname><given-names>W</given-names></name><name><surname>Louache</surname><given-names>F</given-names></name><name><surname>Andrés</surname><given-names>V</given-names></name><name><surname>Méndez-Ferrer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Remodeling of bone marrow hematopoietic stem cell niches promotes myeloid cell expansion during premature or physiological aging</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>407</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.06.007</pub-id><pub-id pub-id-type="pmid">31303548</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Moazzami</surname><given-names>Z</given-names></name><name><surname>Heck</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Nanda</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Bartolomucci</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Chung</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Ruan</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Brown adipose tissue involution associated with progressive restriction in progenitor competence</article-title><source>Cell Reports</source><volume>39</volume><elocation-id>110575</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110575</pub-id><pub-id pub-id-type="pmid">35417710</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Metabolic requirements for the maintenance of self-renewing stem cells</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>15</volume><fpage>243</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1038/nrm3772</pub-id><pub-id pub-id-type="pmid">24651542</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Cho</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>O-Glcnac modification of PPARγ reduces its transcriptional activity</article-title><source>Biochemical and Biophysical Research Communications</source><volume>417</volume><fpage>1158</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.12.086</pub-id><pub-id pub-id-type="pmid">22226965</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajkenova</surname><given-names>O</given-names></name><name><surname>Lecka-Czernik</surname><given-names>B</given-names></name><name><surname>Gubrij</surname><given-names>I</given-names></name><name><surname>Hauser</surname><given-names>SP</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Parfitt</surname><given-names>AM</given-names></name><name><surname>Jilka</surname><given-names>RL</given-names></name><name><surname>Manolagas</surname><given-names>SC</given-names></name><name><surname>Lipschitz</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia</article-title><source>Journal of Bone and Mineral Research</source><volume>12</volume><fpage>1772</fpage><lpage>1779</lpage><pub-id pub-id-type="doi">10.1359/jbmr.1997.12.11.1772</pub-id><pub-id pub-id-type="pmid">9383681</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>SH</given-names></name><name><surname>Byun</surname><given-names>HY</given-names></name><name><surname>Heo</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Oh</surname><given-names>YS</given-names></name><name><surname>Ryu</surname><given-names>SH</given-names></name><name><surname>Suh</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>O-Glcnac modification modulates the expression of osteocalcin via OSE2 and Runx2</article-title><source>Biochemical and Biophysical Research Communications</source><volume>362</volume><fpage>325</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.07.149</pub-id><pub-id pub-id-type="pmid">17707335</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>WJ</given-names></name><name><surname>Shin</surname><given-names>HL</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Ryoo</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RUNX2-modifying enzymes: Therapeutic targets for bone diseases</article-title><source>Experimental &amp; Molecular Medicine</source><volume>52</volume><fpage>1178</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1038/s12276-020-0471-4</pub-id><pub-id pub-id-type="pmid">32788656</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Overview of skeletal development</article-title><source>Methods in Molecular Biology</source><volume>2230</volume><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-1028-2_1</pub-id><pub-id pub-id-type="pmid">33197005</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komori</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>A</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Deguchi</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Bronson</surname><given-names>RT</given-names></name><name><surname>Gao</surname><given-names>YH</given-names></name><name><surname>Inada</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Okamoto</surname><given-names>R</given-names></name><name><surname>Kitamura</surname><given-names>Y</given-names></name><name><surname>Yoshiki</surname><given-names>S</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts</article-title><source>Cell</source><volume>89</volume><fpage>755</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80258-5</pub-id><pub-id pub-id-type="pmid">9182763</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V</given-names></name><name><surname>Moore</surname><given-names>TL</given-names></name><name><surname>Ma</surname><given-names>YL</given-names></name><name><surname>Helvering</surname><given-names>LM</given-names></name><name><surname>Frolik</surname><given-names>CA</given-names></name><name><surname>Valasek</surname><given-names>KM</given-names></name><name><surname>Ducy</surname><given-names>P</given-names></name><name><surname>Geiser</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Parathyroid hormone bone anabolic action requires cbfa1/runx2-dependent signaling</article-title><source>Molecular Endocrinology</source><volume>17</volume><fpage>423</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1210/me.2002-0225</pub-id><pub-id pub-id-type="pmid">12554794</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y-Y</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Qian</surname><given-names>S-W</given-names></name><name><surname>Slawson</surname><given-names>C</given-names></name><name><surname>Dias</surname><given-names>WB</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name><name><surname>Lane</surname><given-names>MD</given-names></name><name><surname>Tang</surname><given-names>Q-Q</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>19248</fpage><lpage>19254</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.005678</pub-id><pub-id pub-id-type="pmid">19478079</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Strecker</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Kronenberg</surname><given-names>MS</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Rowe</surname><given-names>DW</given-names></name><name><surname>Maye</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e71318</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0071318</pub-id><pub-id pub-id-type="pmid">23951132</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues</article-title><source>Experimental Biology and Medicine</source><volume>240</volume><fpage>1099</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1177/1535370215591828</pub-id><pub-id pub-id-type="pmid">26088863</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Salgado</surname><given-names>OC</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Hippen</surname><given-names>KL</given-names></name><name><surname>Maynard</surname><given-names>JC</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Ball</surname><given-names>LE</given-names></name><name><surname>Blazar</surname><given-names>BR</given-names></name><name><surname>Farrar</surname><given-names>MA</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name><name><surname>Ruan</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The lineage stability and suppressive program of regulatory T cells require protein O-glcnacylation</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>354</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08300-3</pub-id><pub-id pub-id-type="pmid">30664665</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>C</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Selig</surname><given-names>MK</given-names></name><name><surname>Torrekens</surname><given-names>S</given-names></name><name><surname>Roth</surname><given-names>SI</given-names></name><name><surname>Mackem</surname><given-names>S</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels</article-title><source>Developmental Cell</source><volume>19</volume><fpage>329</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.07.010</pub-id><pub-id pub-id-type="pmid">20708594</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>MR</given-names></name><name><surname>Dias</surname><given-names>TB</given-names></name><name><surname>Natov</surname><given-names>PS</given-names></name><name><surname>Zachara</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Stress-Induced O-GlcNAcylation: an adaptive process of injured cells</article-title><source>Biochemical Society Transactions</source><volume>45</volume><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1042/BST20160153</pub-id><pub-id pub-id-type="pmid">28202678</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizoguchi</surname><given-names>T</given-names></name><name><surname>Pinho</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>J</given-names></name><name><surname>Kunisaki</surname><given-names>Y</given-names></name><name><surname>Hanoun</surname><given-names>M</given-names></name><name><surname>Mendelson</surname><given-names>A</given-names></name><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development</article-title><source>Developmental Cell</source><volume>29</volume><fpage>340</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.03.013</pub-id><pub-id pub-id-type="pmid">24823377</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>SJ</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The bone marrow niche for haematopoietic stem cells</article-title><source>Nature</source><volume>505</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1038/nature12984</pub-id><pub-id pub-id-type="pmid">24429631</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagel</surname><given-names>AK</given-names></name><name><surname>Schilling</surname><given-names>M</given-names></name><name><surname>Comte-Walters</surname><given-names>S</given-names></name><name><surname>Berkaw</surname><given-names>MN</given-names></name><name><surname>Ball</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of O-linked N-acetylglucosamine (O-GlcNAc) -modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>12</volume><fpage>945</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1074/mcp.M112.026633</pub-id><pub-id pub-id-type="pmid">23443134</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagel</surname><given-names>AK</given-names></name><name><surname>Ball</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>O-Glcnac modification of the runt-related transcription factor 2 (Runx2) links osteogenesis and nutrient metabolism in bone marrow mesenchymal stem cells</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>13</volume><fpage>3381</fpage><lpage>3395</lpage><pub-id pub-id-type="doi">10.1074/mcp.M114.040691</pub-id><pub-id pub-id-type="pmid">25187572</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Ono</surname><given-names>W</given-names></name><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Kronenberg</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>1157</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1038/ncb3067</pub-id><pub-id pub-id-type="pmid">25419849</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>F</given-names></name><name><surname>Thornell</surname><given-names>AP</given-names></name><name><surname>Crompton</surname><given-names>T</given-names></name><name><surname>Denzel</surname><given-names>A</given-names></name><name><surname>Gilmour</surname><given-names>KC</given-names></name><name><surname>Rosewell</surname><given-names>IR</given-names></name><name><surname>Stamp</surname><given-names>GW</given-names></name><name><surname>Beddington</surname><given-names>RS</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name><name><surname>Selby</surname><given-names>PB</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development</article-title><source>Cell</source><volume>89</volume><fpage>765</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80259-7</pub-id><pub-id pub-id-type="pmid">9182764</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phimphilai</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Boules</surname><given-names>H</given-names></name><name><surname>Roca</surname><given-names>H</given-names></name><name><surname>Franceschi</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Bmp signaling is required for Runx2-dependent induction of the osteoblast phenotype</article-title><source>Journal of Bone and Mineral Research</source><volume>21</volume><fpage>637</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1359/jbmr.060109</pub-id><pub-id pub-id-type="pmid">16598384</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>JP</given-names></name><name><surname>Li</surname><given-names>M-D</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Ruan</surname><given-names>H-B</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>13989</fpage><lpage>14000</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.004709</pub-id><pub-id pub-id-type="pmid">30037904</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname><given-names>A</given-names></name><name><surname>Haakonsson</surname><given-names>AK</given-names></name><name><surname>Madsen</surname><given-names>JGS</given-names></name><name><surname>Larsen</surname><given-names>M</given-names></name><name><surname>Forss</surname><given-names>I</given-names></name><name><surname>Madsen</surname><given-names>MR</given-names></name><name><surname>Van Hauwaert</surname><given-names>EL</given-names></name><name><surname>Wiwie</surname><given-names>C</given-names></name><name><surname>Jespersen</surname><given-names>NZ</given-names></name><name><surname>Tencerova</surname><given-names>M</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name><name><surname>Larsen</surname><given-names>BD</given-names></name><name><surname>Röttger</surname><given-names>R</given-names></name><name><surname>Baumbach</surname><given-names>J</given-names></name><name><surname>Scheele</surname><given-names>C</given-names></name><name><surname>Kassem</surname><given-names>M</given-names></name><name><surname>Mandrup</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis</article-title><source>Nature Genetics</source><volume>51</volume><fpage>716</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0359-1</pub-id><pub-id pub-id-type="pmid">30833796</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>HB</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>MD</given-names></name><name><surname>Singh</surname><given-names>JP</given-names></name><name><surname>Qian</surname><given-names>K</given-names></name><name><surname>Azarhoush</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Bennett</surname><given-names>AM</given-names></name><name><surname>Samuel</surname><given-names>VT</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>O-glcnac transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.07.006</pub-id><pub-id pub-id-type="pmid">22883232</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>HB</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Regulation of protein degradation by O-glcnacylation: crosstalk with ubiquitination</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>12</volume><fpage>3489</fpage><lpage>3497</lpage><pub-id pub-id-type="doi">10.1074/mcp.R113.029751</pub-id><pub-id pub-id-type="pmid">23824911</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>HB</given-names></name><name><surname>Singh</surname><given-names>JP</given-names></name><name><surname>Li</surname><given-names>MD</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Cracking the O-glcnac code in metabolism</article-title><source>Trends in Endocrinology and Metabolism</source><volume>24</volume><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2013.02.002</pub-id><pub-id pub-id-type="pmid">23647930</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>HB</given-names></name><name><surname>Dietrich</surname><given-names>MO</given-names></name><name><surname>Liu</surname><given-names>ZW</given-names></name><name><surname>Zimmer</surname><given-names>MR</given-names></name><name><surname>Li</surname><given-names>MD</given-names></name><name><surname>Singh</surname><given-names>JP</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Yin</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>O-Glcnac transferase enables AGRP neurons to suppress browning of white fat</article-title><source>Cell</source><volume>159</volume><fpage>306</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.010</pub-id><pub-id pub-id-type="pmid">25303527</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>H-B</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Torres</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Feriod</surname><given-names>C</given-names></name><name><surname>Heck</surname><given-names>RM</given-names></name><name><surname>Qian</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Nathanson</surname><given-names>MH</given-names></name><name><surname>Bennett</surname><given-names>AM</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Ehrlich</surname><given-names>BE</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Calcium-Dependent O-GlcNAc signaling drives liver autophagy in adaptation to starvation</article-title><source>Genes &amp; Development</source><volume>31</volume><fpage>1655</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1101/gad.305441.117</pub-id><pub-id pub-id-type="pmid">28903979</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheller</surname><given-names>EL</given-names></name><name><surname>Doucette</surname><given-names>CR</given-names></name><name><surname>Learman</surname><given-names>BS</given-names></name><name><surname>Cawthorn</surname><given-names>WP</given-names></name><name><surname>Khandaker</surname><given-names>S</given-names></name><name><surname>Schell</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Ding</surname><given-names>SY</given-names></name><name><surname>Bredella</surname><given-names>MA</given-names></name><name><surname>Fazeli</surname><given-names>PK</given-names></name><name><surname>Khoury</surname><given-names>B</given-names></name><name><surname>Jepsen</surname><given-names>KJ</given-names></name><name><surname>Pilch</surname><given-names>PF</given-names></name><name><surname>Klibanski</surname><given-names>A</given-names></name><name><surname>Rosen</surname><given-names>CJ</given-names></name><name><surname>MacDougald</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7808</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8808</pub-id><pub-id pub-id-type="pmid">26245716</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheller</surname><given-names>EL</given-names></name><name><surname>Cawthorn</surname><given-names>WP</given-names></name><name><surname>Burr</surname><given-names>AA</given-names></name><name><surname>Horowitz</surname><given-names>MC</given-names></name><name><surname>MacDougald</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Marrow adipose tissue: Trimming the fat</article-title><source>Trends in Endocrinology and Metabolism</source><volume>27</volume><fpage>392</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2016.03.016</pub-id><pub-id pub-id-type="pmid">27094502</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>HS</given-names></name><name><surname>Liu</surname><given-names>YL</given-names></name><name><surname>Tang</surname><given-names>XT</given-names></name><name><surname>Zhang</surname><given-names>XS</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>BO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tracing the skeletal progenitor transition during postnatal bone formation</article-title><source>Cell Stem Cell</source><volume>28</volume><fpage>2122</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2021.08.010</pub-id><pub-id pub-id-type="pmid">34499868</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>K</given-names></name><name><surname>DelProposto</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>DL</given-names></name><name><surname>Zamarron</surname><given-names>B</given-names></name><name><surname>Mergian</surname><given-names>T</given-names></name><name><surname>Maley</surname><given-names>N</given-names></name><name><surname>Cho</surname><given-names>KW</given-names></name><name><surname>Geletka</surname><given-names>L</given-names></name><name><surname>Subbaiah</surname><given-names>P</given-names></name><name><surname>Muir</surname><given-names>L</given-names></name><name><surname>Martinez-Santibanez</surname><given-names>G</given-names></name><name><surname>Lumeng</surname><given-names>CN-K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Diet-Induced obesity promotes myelopoiesis in hematopoietic stem cells</article-title><source>Molecular Metabolism</source><volume>3</volume><fpage>664</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2014.06.005</pub-id><pub-id pub-id-type="pmid">25161889</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Lan</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Zuo</surname><given-names>R</given-names></name><name><surname>Xing</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glucose regulates tissue-specific chondro-osteogenic differentiation of human cartilage endplate stem cells via O-glcnacylation of SOX9 and runx2</article-title><source>Stem Cell Research &amp; Therapy</source><volume>10</volume><elocation-id>357</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-019-1440-5</pub-id><pub-id pub-id-type="pmid">31779679</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takarada</surname><given-names>T</given-names></name><name><surname>Nakazato</surname><given-names>R</given-names></name><name><surname>Tsuchikane</surname><given-names>A</given-names></name><name><surname>Fujikawa</surname><given-names>K</given-names></name><name><surname>Iezaki</surname><given-names>T</given-names></name><name><surname>Yoneda</surname><given-names>Y</given-names></name><name><surname>Hinoi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic analysis of runx2 function during intramembranous ossification</article-title><source>Development</source><volume>143</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1242/dev.128793</pub-id><pub-id pub-id-type="pmid">26657773</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gastel</surname><given-names>N</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Metabolic regulation of skeletal cell fate and function in physiology and disease</article-title><source>Nature Metabolism</source><volume>3</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-00321-3</pub-id><pub-id pub-id-type="pmid">33398192</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Rong</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Ccaat/enhancer-binding proteins in fibrosis: complex roles beyond conventional understanding</article-title><source>Research</source><volume>2022</volume><elocation-id>9891689</elocation-id><pub-id pub-id-type="doi">10.34133/2022/9891689</pub-id><pub-id pub-id-type="pmid">36299447</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Frenette</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Niches for hematopoietic stem cells and their progeny</article-title><source>Immunity</source><volume>48</volume><fpage>632</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.03.024</pub-id><pub-id pub-id-type="pmid">29669248</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whelan</surname><given-names>SA</given-names></name><name><surname>Lane</surname><given-names>MD</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>21411</fpage><lpage>21417</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800677200</pub-id><pub-id pub-id-type="pmid">18519567</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Protein O-GlcNAcylation: Emerging mechanisms and functions</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>18</volume><fpage>452</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.22</pub-id><pub-id pub-id-type="pmid">28488703</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>VWC</given-names></name><name><surname>Lymperi</surname><given-names>S</given-names></name><name><surname>Oki</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Swiatek</surname><given-names>P</given-names></name><name><surname>Vasic</surname><given-names>R</given-names></name><name><surname>Ferraro</surname><given-names>F</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinctive mesenchymal-parenchymal cell pairings govern B cell differentiation in the bone marrow</article-title><source>Stem Cell Reports</source><volume>7</volume><fpage>220</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2016.06.009</pub-id><pub-id pub-id-type="pmid">27453006</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Ong</surname><given-names>B</given-names></name><name><surname>Sahu</surname><given-names>C</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Ruan</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bone marrow adipose tissue-derived stem cell factor mediates metabolic regulation of hematopoiesis</article-title><source>Haematologica</source><volume>104</volume><fpage>1731</fpage><lpage>1743</lpage><pub-id pub-id-type="doi">10.3324/haematol.2018.205856</pub-id><pub-id pub-id-type="pmid">30792196</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Robles</surname><given-names>H</given-names></name><name><surname>Magee</surname><given-names>KL</given-names></name><name><surname>Lorenz</surname><given-names>MR</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Harris</surname><given-names>CA</given-names></name><name><surname>Craft</surname><given-names>CS</given-names></name><name><surname>Scheller</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A bone-specific adipogenesis pathway in fat-free mice defines key origins and adaptations of bone marrow adipocytes with age and disease</article-title><source>eLife</source><volume>10</volume><elocation-id>e66275</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.66275</pub-id><pub-id pub-id-type="pmid">34378533</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>K</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Alejandro</surname><given-names>EU</given-names></name><name><surname>Ruan</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protein O-glcnac modification links dietary and gut microbial cues to the differentiation of enteroendocrine L cells</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>108013</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108013</pub-id><pub-id pub-id-type="pmid">32783937</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Ming</given-names></name><name><surname>Ren</surname><given-names>K</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Xin</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Maynard</surname><given-names>JC</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Battist</surname><given-names>AP</given-names></name><name><surname>Koneripalli</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Xin</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Salgado</surname><given-names>OC</given-names></name><name><surname>Jarjour</surname><given-names>NN</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name><name><surname>Revelo</surname><given-names>XS</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Ruan</surname><given-names>H-B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and gasdermin C</article-title><source>Immunity</source><volume>55</volume><fpage>623</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2022.03.009</pub-id><pub-id pub-id-type="pmid">35385697</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Tower</surname><given-names>RJ</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Miao</surname><given-names>Z</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Shrestha</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Holdreith</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Tong</surname><given-names>W</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Susztak</surname><given-names>K</given-names></name><name><surname>Dyment</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment</article-title><source>eLife</source><volume>9</volume><elocation-id>e54695</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54695</pub-id><pub-id pub-id-type="pmid">32286228</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>BO</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Yue</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Rios</surname><given-names>JJ</given-names></name><name><surname>Naveiras</surname><given-names>O</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>891</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1038/ncb3570</pub-id><pub-id pub-id-type="pmid">28714970</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>ZK</given-names></name><name><surname>Jiang</surname><given-names>XX</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>XY</given-names></name><name><surname>Yao</surname><given-names>HY</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone</article-title><source>Nature Protocols</source><volume>5</volume><fpage>550</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.238</pub-id><pub-id pub-id-type="pmid">20203670</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85464.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yunlei</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Albert Einstein College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.12.21.521379" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.21.521379"/></front-stub><body><p>Bone marrow stromal cells (BMSCs) can differentiate into a variety of cell types such as osteoblasts, chondrocytes, and adipocytes. The authors of this important study provide compelling and strong evidence that ablating O-GlcNAc transferase (OGT) in BMSCs impairs bone formation but promotes marrow adiposity. The results show that the balance of osteogenic and adipogenic differentiation of BMSCs is controlled by reciprocal O-GlcNAc regulation of lineage-specifying transcription factors, and highlights the importance of an intracellular glycosylation process of specific proteins in establishing the BM niche for hematopoiesis.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85464.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yang</surname><given-names>Yunlei</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Albert Einstein College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Horvath</surname><given-names>Tamas L</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Shinoda</surname><given-names>Kosaku</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Albert Einstein College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.21.521379">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.12.21.521379v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Tamas L Horvath (Reviewer #1); Kosaku Shinoda (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>There is no need to provide new data. In order to improve the manuscript, please substantially address the reviewers' questions or concerns to revise the manuscript. Meanwhile, please provide point-to-point responses to the editors' and reviewers' comments.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>In my judgment, this paper is appropriate for publication. I would request that the authors detail the results in relation to males versus females in each experiment.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>I will mainly comment on the biology of adipocytes, which is my specialty.</p><p>The point that O-GlcNAc regulates adipocyte differentiation has been convincingly demonstrated, but the molecular mechanism has not been fully explored. The data that C/EBPβ increases transcriptional activity by mutating O-GlcNAc sites, but does this happen independently of protein level, or is it due to altered protein stability (ubiquitination)? Also, downstream of O-GlcNAcylated C/EBPβ, does Pparg expression change at the protein level, and is there a change in its interaction with the binding partner, C/EBPalpha? If these points are clarified, this would be an excellent paper that could be laid out more generally in adipocyte research.</p><p>I also have a concern about the PDGFRa+VCAM1+ population of adipocyte progenitors, which the authors have shown to be unregulated by approximately 30% by knockout of Ogt (Figure 4C). How developmentally significant this difference is? Looking at panel A of the same figure, the phenotype seems to be a more qualitative difference, but can a 30% difference in PDGFRa+ explain it? Rather, could this be through turning on the expression of Pparg, which indicates lineage commitment, be more important? Sca-1 is commonly used as a marker for adipogenic MSCs – authors should cite a paper showing that PDGFRa+VCAM1+ is a selective marker for adipogenic cells and a detailed protocol for the FACS should also be added in the Materials and methods section. For example, which lineage markers were used to deplete non-adipogenic cells?</p><p>Finally, what regulates O-GlcNAcylation of C/EBPβ? Does aging or a Western diet regulate this PTM? Pursuing this will strengthen the significance of this novel regulatory layer of adipogenesis.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85464.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>In my judgment, this paper is appropriate for publication. I would request that the authors detail the results in relation to males versus females in each experiment.</p></disp-quote><p>I appreciate Reviewer #1’s enthusiasm and recommendation on manuscript. Thankyou.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>I will mainly comment on the biology of adipocytes, which is my specialty.</p><p>The point that O-GlcNAc regulates adipocyte differentiation has been convincingly demonstrated, but the molecular mechanism has not been fully explored. The data that C/EBPβ increases transcriptional activity by mutating O-GlcNAc sites, but does this happen independently of protein level, or is it due to altered protein stability (ubiquitination)? Also, downstream of O-GlcNAcylated C/EBPβ, does Pparg expression change at the protein level, and is there a change in its interaction with the binding partner, C/EBPalpha? If these points are clarified, this would be an excellent paper that could be laid out more generally in adipocyte research.</p></disp-quote><p>These are great points. We have Western blotting data (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>) demonstrating that O-GlcNAc mutant C/EBPβ did not change its protein expression. This is consistent with our previous study in other cell types (Qian et al., 2018). We have not determined if protein stability or ubiquitination are affected, because we did not see any change in its protein level. Regarding PPARγ, we observed increased gene expression when mutant C/EBPβ was expressed in C3H10T<sub>1/2</sub> cells (Figure 4H), suggesting adipogenic activation. We did not measure PPARγ protein levels or its interaction with C/EBPα, the latter of which is an important question and will be addressed in our future experiments.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85464-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>I also have a concern about the PDGFRa+VCAM1+ population of adipocyte progenitors, which the authors have shown to be unregulated by approximately 30% by knockout of Ogt (Figure 4C). How developmentally significant this difference is? Looking at panel A of the same figure, the phenotype seems to be a more qualitative difference, but can a 30% difference in PDGFRa+ explain it? Rather, could this be through turning on the expression of Pparg, which indicates lineage commitment, be more important? Sca-1 is commonly used as a marker for adipogenic MSCs – authors should cite a paper showing that PDGFRa+VCAM1+ is a selective marker for adipogenic cells and a detailed protocol for the FACS should also be added in the Materials and methods section. For example, which lineage markers were used to deplete non-adipogenic cells?</p></disp-quote><p>We agree with the reviewer that the 30% increase in PDGFRa<sup>+</sup>VCAM1<sup>+</sup> adipose progenitors cannot fully explain the BM adiposity observed in <italic>Ogt</italic> cKO animals. A simultaneous augmentation in adipogenic differentiation is most likely. Indeed, we provided in vitro evidence that genetic deletion or chemical inhibition of OGT significant increases adipogenesis (Figure 4D-I). With scRNA-sequencing, our unpublished data and publicly available datasets by others (Baryawno et al., 2019; Zhong et al., 2020) have repeatedly showed that <italic>Pdgra</italic><sup>+</sup>/<italic>Vcam1</italic><sup>+</sup> doulble positive cells overlap with <italic>Lepr</italic><sup>+</sup>/<italic>Adipoq</italic><sup>+</sup> adipogenic progenitors (also known as MALP and Adipo-CAR cells in some publications). On the other hand, the <italic>Ly6a</italic> gene (encoding Sca-1) marks a more primitive population of mesenchymal stem cells (Zhong <italic>et al.</italic>, 2020). Expression of these genes at the single cell level are now provided in Figure 4—figure supplement 1<bold>.</bold> To increase rigor, we have now provided detailed flow cytometry protocol (including negative lineage markers) in the Methods section.</p><disp-quote content-type="editor-comment"><p>Finally, what regulates O-GlcNAcylation of C/EBPβ? Does aging or a Western diet regulate this PTM? Pursuing this will strengthen the significance of this novel regulatory layer of adipogenesis.</p></disp-quote><p>Those are all great questions. The short answer is that we do not know yet (as we briefly discussed in the 3<sup>rd</sup> paragraph in the Discussion section). The fact that PTH is sufficient to induce protein O-GlcNAcylation (Figure 2D) would support the prediction that aging perturbs C/EBPβ O-GlcNAcylation and the bone-fat balance. In fact, we are actively investigating these possibilities using the <italic>Lepr<sup>Cre</sup></italic> (instead of <italic>Sp7<sup>GFP:Cre</sup></italic>) mice to target OGT in adult perivascular BMSCs. We are excited about the preliminary data we have collected so far and expect to report our findings in very near future.</p><p>Reference:</p><p>Baryawno, N., Przybylski, D., Kowalczyk, M.S., Kfoury, Y., Severe, N., Gustafsson, K., Kokkaliaris, K.D., Mercier, F., Tabaka, M., Hofree, M., et al. (2019). A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia. Cell <italic>177</italic>, 1915-1932 e1916. 10.1016/j.cell.2019.04.040.</p><p>Chen, J., Shi, Y., Regan, J., Karuppaiah, K., Ornitz, D.M., and Long, F. (2014). Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice. PLoS One <italic>9</italic>, e85161. 10.1371/journal.pone.0085161.</p><p>Ji, S., Park, S.Y., Roth, J., Kim, H.S., and Cho, J.W. (2012). O-GlcNAc modification of PPARgamma reduces its transcriptional activity. Biochem Biophys Res Commun <italic>417</italic>, 1158-1163. 10.1016/j.bbrc.2011.12.086.</p><p>Li, M.D., Vera, N.B., Yang, Y., Zhang, B., Ni, W., Ziso-Qejvanaj, E., Ding, S., Zhang, K., Yin, R., Wang, S., et al. (2018). Adipocyte OGT governs diet-induced hyperphagia and obesity. Nat Commun <italic>9</italic>, 5103. 10.1038/s41467-018-07461-x.</p><p>Qian, K., Wang, S., Fu, M., Zhou, J., Singh, J.P., Li, M.D., Yang, Y., Zhang, K., Wu, J., Nie, Y., et al. (2018). Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer. J Biol Chem <italic>293</italic>, 13989-14000. 10.1074/jbc.RA118.004709.</p><p>Rodda, S.J., and McMahon, A.P. (2006). Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development <italic>133</italic>, 3231-3244. 10.1242/dev.02480.</p><p>Scheller, E.L., Doucette, C.R., Learman, B.S., Cawthorn, W.P., Khandaker, S., Schell, B., Wu, B., Ding, S.Y., Bredella, M.A., Fazeli, P.K., et al. (2015). Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nat Commun <italic>6</italic>, 7808. 10.1038/ncomms8808.</p><p>Yang, Y., Fu, M., Li, M.D., Zhang, K., Zhang, B., Wang, S., Liu, Y., Ni, W., Ong, Q., Mi, J., and Yang, X. (2020). O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity. Nat Commun <italic>11</italic>, 181. 10.1038/s41467-019-13914-8.</p><p>Zhang, X., Robles, H., Magee, K.L., Lorenz, M.R., Wang, Z., Harris, C.A., Craft, C.S., and Scheller, E.L. (2021). A bone-specific adipogenesis pathway in fat-free mice defines key origins and adaptations of bone marrow adipocytes with age and disease. e<italic>Life 10</italic>. 10.7554/<italic>eLife</italic>.66275.</p><p>Zhong, L., Yao, L., Tower, R.J., Wei, Y., Miao, Z., Park, J., Shrestha, R., Wang, L., Yu, W., Holdreith, N., et al. (2020). Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. e<italic>Life 9</italic>. 10.7554/<italic>eLife</italic>.54695.</p></body></sub-article></article>